Stoke Therapeutics Inc. and Biogen Inc. said Tuesday they are entering a collaboration to develop and commercialize a ...
The deal, which features up to $385 million in milestones, gives Biogen exclusive rights to commercialize Stoke’s ...
A dad was diagnosed with four of the deadliest brain tumours after feeling 'tingles' in his left arm for a month - and died ...
Norwich comfortably saw off Stoke 4-2 at Carrow Road to record their first win in four matches and reignite their bid to ...
Chardan Capital reissued their buy rating on shares of Stoke Therapeutics (NASDAQ:STOK – Free Report) in a research note issued to investors on Wednesday,Benzinga reports. The firm currently has a $24 ...
From my colleague Adam Feuerstein: Biogen and Stoke Therapeutics have signed a partnership agreement to co-develop and sell ...
The school leaders taking unprecedented action to ensure a safe learning environment with amenities in good working order ...
Mark Robins warned Stoke City will get punished if they sit off teams as much as they did in the first half at Norwich or lose discipline like they did in the second. Stoke were beaten 4-2 at Carrow ...
In exchange for $165 million, Biogen now has access to zorevunersen, a potential first-of-its-kind treatment for Dravet ...
Stoke Therapeutics Inc. (Nasdaq: STOK) has pulled in Biogen (Nasdaq: BIIB) to help it develop and commercialize a treatment ...
An arsonist with 'extremist views' and who once set fire to a Stoke-on-Trent Thornton's shop said he has 'no remorse' for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results